States resumed offering Johnson & Johnson’s Covid-19 vaccine this weekend following a pause over blood-clotting concerns #WSJWhatsNowt.co
@axios.com4 years ago
FDA analysis finds Johnson & Johnson COVID vaccine is safe and effective
@WSJ4 years ago
Use of Johnson & Johnson's Covid-19 vaccine should resume, U.S. health regulators said. The shots could be back in circulation as soon as this weekend. on.wsj.com
@WSJ4 years ago
Johnson & Johnson bet big on a new vaccine technology a decade ago. It paid off this weekend with U.S. approval of its Covid-19 shot. Here's how they did it. on.wsj.com
@vox.com4 years ago
FDA advisers unanimously recommend Johnson & Johnson’s Covid-19 vaccine